OPEN MARKET SALE AGREEMENTSM4D Molecular Therapeutics Inc. • March 29th, 2022 • Biological products, (no disgnostic substances) • New York
Company FiledMarch 29th, 2022 Industry Jurisdiction
OPEN MARKET SALE AGREEMENTSM4D Molecular Therapeutics Inc. • March 29th, 2022 • Biological products, (no disgnostic substances) • New York
Company FiledMarch 29th, 2022 Industry Jurisdiction